3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
94
Prostatic Neoplasms, Castration-Resistant
10
Neoplasm Metastasis
8
Breast Neoplasms
8
Neoplasms
7
Triple Negative Breast Neoplasms
4
Metastatic Castration-Resistant Prostate Cancer
4
Carcinoma, Non-Small-Cell Lung
4
Small Cell Lung Carcinoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Melanoma
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Bulbo-Spinal Atrophy, X-Linked
3
Adenocarcinoma
3
mCRPC
2
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Prostate Adenocarcinoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Metastatic Hormone-sensitive Prostate Cancer
2
Metastatic Hormone Sensitive Prostate Cancer
2
Metastatic Castration-resistant Prostate Cancer
2
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
2
Bites and Stings
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Interventions
fludarabine
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
isatuximab
1
ibrutinib
1
Lenalidomide
1
Dexamethasone
1
CLR1404
1
CA-4948
1
Bortezomib
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoproliferative Disorders
×
enzalutamide
×
1 year
×
Clear all
No trials found.